Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers

BACKGROUND: The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. Here, we aimed to find protein markers in cerebrospinal fluid (CSF) from patient...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Neurodegener
Egile Nagusiak: Remnestål, Julia, Öijerstedt, Linn, Ullgren, Abbe, Olofsson, Jennie, Bergström, Sofia, Kultima, Kim, Ingelsson, Martin, Kilander, Lena, Uhlén, Mathias, Månberg, Anna, Graff, Caroline, Nilsson, Peter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7310563/
https://ncbi.nlm.nih.gov/pubmed/32576262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-020-00198-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak